Abstract
Background and Aims Initial use of drugs such as tobacco and alcohol may lead to subsequent more problematic drug use – the ‘gateway’ hypothesis. However, observed associations may be due to a shared underlying risk factor, such as trait impulsivity. We used bidirectional Mendelian Randomisation (MR) to test the gateway hypothesis.
Design Our main method was inverse-variance weighted (IVW) MR, with other methods included as sensitivity analyses (where consistent results across methods would raise confidence in our primary results). MR is a genetic instrumental variable approach used to support stronger causal inference in observational studies.
Setting European ancestry individuals.
Participants Genome-wide association summary data for smoking initiation, alcoholic drinks per week, cannabis use and dependence, cocaine and opioid dependence (N=1,749 to 1,232,091).
Measurements Genetic variants for exposure.
Findings We found evidence of causal effects from smoking initiation to increased drinks per week (IVW: β=0.06; 95% CI=0.03 to 0.09; p=9.44×10−06), cannabis use (IVW: OR=1.34; 95% CI=1.24 to 1.44; p=1.95×10−14), and cannabis dependence (IVW: OR=1.68; 95% CI=1.12 to 2.51; p=0.01). We also found evidence of an effect of cannabis use on increased likelihood of smoking initiation (IVW: OR=1.39; 95% CI=1.08 to 1.80; p=0.01). We did not find evidence of an effect of drinks per week on other substance use outcomes, except weak evidence of an effect on cannabis use. We found weak evidence of an effect of opioid dependence on increased drinks per week (IVW: β=0.002; 95% CI=0.0005 to 0.003; p=8.61×10−03).
Conclusions Smoking initiation may lead to increased alcohol consumption, cannabis use and dependence. Cannabis use may also lead to smoking initiation, and opioid dependence to alcohol consumption. However, given tobacco and alcohol use typically begin before other drug use, these results may reflect a shared risk factor, or a bidirectional effect for cannabis use. Further research should explore potentially shared risk factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by Public Health England, the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (Grant ref: MC_UU_00011/7), and the National Institute for Health Research (NIHR) Biomedical Research Centre at the University Hospitals Bristol National Health Service Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. Robyn Wootton was supported by a postdoctoral fellowship from the South-Eastern Regional Health Authority (2020024).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos